Gynecological Cancer Drugs; Depends On the Kind of Cancer and How Far It Has Spread
Gynaecological cancer drugs are used for the treatment of gynaecological or gynecologic cancer, a cancer that starts in the woman's reproductive organs. The cancer begin in different places within a woman's pelvis, which is the area below the stomach and in between the hip bones. It is always named for the part of the body where it starts, including cervical cancer, vaginal cancer, ovarian cancer, uterine cancer, and vulvar cancer. As a group, they are referred to as gynecologic cancer. A sixth type of gynecologic cancer is the very rare fallopian tube cancer.
All
women are at risk for Gynecological
Cancer Drugs, and risk increases with the age.
When gynecologic cancers are found early, treatment is most effective. Risk
factors for gynecologic cancers include diabetes, older age, high fat diet, and
more. Each cancer is unique, with different signs/symptoms, different risk
factors, and different prevention strategies. Several other factors, such as
late start of menopause, early start of menstruation, mutations, obesity,
infertility, and Human Papillomavirus are responsible for the occurrence of
gynecological cancer.
Thus,
there is an increasing demand for safe and effective treatment and/or drugs. Treatments
may include surgery, chemotherapy, and radiation. Gynecologic cancers are
treated in several ways. Gynecological Cancer
Drugs depend on the kind of cancer and how far
it has spread. The U.S. Food and Drug Administration (FDA) has approved several
gynaecological cancer drugs, such as Lynparza (Olaparib), Cisplatin, Carboplatin,
Bevacizumab, Avastin (Bevacizumab), Tepadina (Thiotepa), Alkeran (Melphalan),
and Alymsys (Bevacizumab) to treat variety of gynecologic cancer.
Ovarian
cancer ranks fifth in cancer deaths among women, accounting for more deaths
than any other cancer of the female reproductive system. Around 100,000 women in
the United States are diagnosed with gynecologic cancer each year. Family
history, obesity, age, and HPV are important risk factors for gynecologic
cancer. Therefore, there is an increase in demand for safe and effective Gynecological Cancer Drugs in
the U.S.
Comments
Post a Comment